Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNK3 | O14649 | 6/20 | 0.76 |
| ▸ | KCNK9 | Q9NPC2 | 5/20 | 0.76 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.69 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.67 |
| ▸ | RAB9A | P51151 | 4/20 | 0.65 |
| ▸ | NPC1 | O15118 | 3/20 | 0.65 |
| ▸ | HPGD | P15428 | 1/20 | 0.65 |
| ▸ | DDX3X | O00571 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 4/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.63 |
| ▸ | TP53 | P04637 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8399784 | 0.93 | PTGS1 (0.79) | KCNK3KCNK9PTGS1SIRT1RAB9A | |
| SCHEMBL29568808 | 0.93 | PTGS1 (0.79) | KCNK3KCNK9PTGS1SIRT1RAB9A | |
| SCHEMBL29568967 | 0.91 | PTGS1 (0.72) | KCNK3KCNK9PTGS1DDX3XMEN1 | |
| SCHEMBL308208 | 0.91 | PTGS1 (0.72) | KCNK3KCNK9PTGS1SIRT1DDX3X | |
| SCHEMBL31171978 | 0.91 | PTGS1 (0.72) | KCNK3KCNK9PTGS1SIRT1DDX3X | |
| SCHEMBL8403932 | 0.91 | PTGS1 (0.72) | KCNK3KCNK9PTGS1DDX3XMEN1 | |
| SCHEMBL1337455 | 0.90 | PTPN1 (0.67) | KCNK3KCNK9PTGS1RAB9ANPC1 | |
| Hydrochloric Acid SCHEMBL11740733 | 0.89 | PTGS1 (0.70) | KCNK3KCNK9PTGS1DDX3XMEN1 | |
| SCHEMBL29672230 | 0.89 | PTGS1 (0.74) | KCNK3KCNK9PTGS1SIRT1RAB9A | |
| SCHEMBL1352405 | 0.89 | PTGS1 (0.68) | KCNK3KCNK9PTGS1SIRT1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 277 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101273009-B | Insecticidal 3-acylaminobenzanilides | BAYER CROPSCIENCE AG | 2012-09-05 | — | — | CN | claimed |
| EP-1814545-A4 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | IRM LLC (BM) | 2009-06-10 | — | — | EP | claimed |
| US-20080221192-A1 | Compounds and Compositions as Protein Kinase Inhibitors | IRM LLC (BM) | 2008-09-11 | — | — | US | claimed |
| EP-1814545-A2 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | IRM, LLC (BM) | 2007-08-08 | — | — | EP | claimed |
| WO-2006052936-A2 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | IRM LLC (BM) | 2006-05-18 | — | — | WO | claimed |
| CN-1235886-C | Method for preparing sulfhydyl-(m-benzamido) phenyl tetrazole | HUAFENG CHEMICAL CO LTD NANTON (CN) | 2006-01-11 | — | — | CN | claimed |
| EP-4705291-A1 | IKK-ALPHA INHIBITORS | Cancer Research Technology Limited (GB) | 2026-03-11 | — | — | EP | disclosed |
| US-20250352542-A1 | TRPV2 CHANNEL BLOCKERS AND USE THEREOF | ICHILOV TECH LTD. (IL) | 2025-11-20 | — | — | US | disclosed |
| EP-4551568-A1 | TRPV2 CHANNEL BLOCKERS AND USE THEREOF | Ichilov Tech Ltd. (IL) | 2025-05-14 | — | — | EP | disclosed |
| CN-119816492-A | TRPV2 channel blocker and use thereof | 伊契洛夫科技有限公司 | 2025-04-11 | — | — | CN | disclosed |
| CN-119306730-A | Cyclic ether modified 3-cyano-4-arylaminoquinoline derivative as well as preparation method and application thereof | 河北医科大学 | 2025-01-14 | — | — | CN | disclosed |
| WO-2024228035-A1 | IKK-ALPHA INHIBITORS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2024-11-07 | — | — | WO | disclosed |
| US-20240277852-A1 | INHIBITORS AND DEGRADERS OF PIP4K PROTEIN | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2024-08-22 | — | — | US | disclosed |
| US-4080321-A | COLORFASTNESS | HOECHST AKTIENGESELLSCHAFT (DT) | 1978-03-21 | — | — | US | disclosed |
| US-4057518-A | Process for the manufacture of heat resistant multicellular materials | RHONE-POULENC INDUSTRIES (FR) | 1977-11-08 | — | — | US | disclosed |
| US-4032532-A | AZO DYES | SANDOZ LTD. (CH) | 1977-06-28 | — | — | US | disclosed |
| US-4013600-A | STORAGE STABILITY | RHONE-POULENC INDUSTRIES (FR) | 1977-03-22 | — | — | US | disclosed |
| US-4010220-A | AMINO COMPOUND, POLYURETHANE ELASTOMER | RHONE-POULENC INDUSTRIES (FR) | 1977-03-01 | — | — | US | disclosed |
| US-4007213-A | Process for preparing 1-(N-β-cyanethylaminol-3-acylaminobenzenes | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-02-08 | — | — | US | disclosed |
| US-3998803-A | TEXTILES | FIDELITY UNION TRUST COMPANY, EXECUTIVE TRUSTEE UNDER THE SANDOZ TRUST (US) | 1976-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250352542-A1 | TRPV2 CHANNEL BLOCKERS AND USE THEREOF | TRPV2, TRPV1, TRPA1 | KCNK3 171/4885KCNK9 264/4885PTGS1 130/4885 |
| US-20240277852-A1 | INHIBITORS AND DEGRADERS OF PIP4K PROTEIN | PIP4K2A, PIP4K2C, PIP4K2B | KCNK3 2122/4885KCNK9 2339/4885PTGS1 3789/4885 |
| US-20080221192-A1 | Compounds and Compositions as Protein Kinase Inhibitors | BMX, FRK, PTK2B | KCNK3 874/4885KCNK9 1165/4885PTGS1 3980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.